The Asia–Gulf corridor and the patient

Consider anyone who moves from Asia to work in the Gulf: an engineer from Manila, a nurse from Kochi, a driver from Dhaka, a finance manager from Lahore.

On their first day in the new country, their medical history is a blank page. Years of check-ups, vaccination records, the reason they cannot take a certain antibiotic: none of it comes with them. Their new doctor starts from zero. If they bring their children, the school will ask for vaccination proof that sits in a drawer back home.

Then the cycle begins. Many expatriates from Asia fly home once a year and use the visit for a check-up with the family doctor they trust. The results stay there, on paper or in a local system. Back in the Gulf, their physician never sees them. When they change job or move to a neighbouring Gulf country, the same thing happens again.

And when they finally return home for good, the longest chapter of their medical life, often twenty years of it, stays behind in the Gulf. Each move resets their history. I know this cycle first-hand: my own records are scattered between France and the UAE.

Their story is the norm, not the exception. Asian workers and their families number in the tens of millions across the Gulf states, and in several of them expatriates are the large majority of residents.

We usually discuss this corridor in terms of trade, energy and remittances. We rarely discuss it in terms of health. We should.

The corridor runs both ways

Care does not only flow from Asia to the Gulf. Gulf citizens and residents travel east for treatment, to cities such as Bangkok, Singapore and Seoul, drawn by the quality of care and often by the price. Many go for planned procedures; others go for second opinions on serious diagnoses, where every past result matters.

Picture a patient from the Gulf meeting a specialist in Asia for the first time. She arrives with a folder: prescriptions, past medications, scan reports, lab results printed in different units and languages. The specialist has to piece together a history from loose paper, in a consultation that may last thirty minutes.

The treatment goes well. She flies home with new reports, a new medication plan and follow-up instructions. Her doctor at home receives them, if at all, as another stack of paper to interpret. The care was excellent; the continuity of care was not.

Older patients and those with chronic conditions have the most to lose, because they carry the longest histories and take the most medicines. The cost is real on both routes: repeated tests, delayed diagnoses, medication errors, and the quiet risk of an allergy nobody knew about.

Vitalls gives patients a passport to better health

The patient is the one constant

The instinctive answer is to connect national systems, and many countries in both regions now run advanced health information exchanges.

But linking them across borders means aligning privacy laws, data residency rules and bilateral agreements, which takes years, and such links rarely reach the private clinic where most expatriates and medical travellers actually receive care. Governments are right to be cautious: health data is among the most sensitive information a state holds.

There is a simpler principle. In every one of these journeys, one person was present at every consultation: the patient. The record should travel with them.

A patient-controlled model changes the question. Instead of institutions negotiating to move data between each other, the individual holds their own history and decides, visit by visit, who sees it and for how long.

Consent is explicit, specific and revocable. For the doctor, the difference is concrete: a reliable history in minutes, instead of guesswork built from a patient’s memory. No central body accumulates health data on behalf of providers. The data crosses a border because its owner carries it, not because one state has asked another for access.

Vitalls secures US$1.5 million investment commitment from EST Growmore

What it will take

Three things will make this work across the corridor.

First, a shared clinical language: standards such as FHIR, LOINC and SNOMED CT already exist, so a blood test can mean the same thing in any language or unit.

Second, trusted digital identity, so a doctor knows a record belongs to the person in the chair. Third, privacy by design, with personal identifiers protected before anything leaves the patient’s device.

Regulators on both sides can help by recognising patient-held records as valid clinical input, and by agreeing common standards rather than common databases.

The Asia–Gulf corridor has already shown it can move people, goods and capital at extraordinary scale. The next test is whether it can move care. The answer will not come from a single treaty or a single platform. It will come from a principle: the record belongs to the patient, and it should travel with them.